nordic society of nephrology - mkon.nu · 34th biennial congress of the malmö live sweden...

34th Biennial Congress of the

Malmö Live Sweden September 20-23 2017NORDIC SOCIETY OF NEPHROLOGY

Wednesday September 20th

18.00 - 18.15 Opening remarksKerstin Westman & Stefan Lamme, Region Skåne

18.15 - 19.00 State of the art lectureChair: Anders Christensson

Renal ischemia and its consequences - Fredrik Palm, Uppsala, Sweden

Welcome greetings - the Okta-Vera choir

19.00-21.00 Get togheter in the exhibition area at Malmö Live

Thursday September 21st

08.00 - 08.30 Sponsor lecture - AstraZeneca

Hyperkalemia in chronic kidney disease

Prevalence, incidence and risk

Management of hyperkalemia

08.30 - 10.00 Diabetic kidney diseaseChair: Anders Frid

Diabetic nephropathy – Pathogenesis. New insights - Per-Henrik Groop, Helsinki, Finland

Prediabetes. Experiences from the Tromsø Study (RENIS-T6) - Toralf Melsom, Tromsø, Norway

Urine proteomics in early diabetic kidney disease - Peter Rossing, Copenhagen, Denmark

10.00 - 10.30 Coffee and exhibition

10.30 - 12.00 TransplantationChair: Marie Felldin

Pancreas transplantation - Alireza Biglarnia, Malmö, Sweden

Immunology of organ transplantation. An update - Kathryn Wood, Oxford, UK

Tolerance in organ transplantation - David Berglund, Uppsala/Stockholm, Sweden

12.00 - 13.30 Lunch and exhibition

13.30 - 14.15 Best abstracts - oral presentationsChair: Greger Guron

The Effect of Parathyroidectomy on Risk of Hip Fracture in Swedish Patients in Renal Replacement Therapy - Elin Isaksson, Malmö, Sweden

Early Failure of Kidney Transplants in the Current Era - Ilkka Helanterä, Helsinki, Finland

Glomerular extracellular matrix protein changes in IgA nephropathy - Flavia Teodora Ioana Paunas, Kolnes, Norway

Mild Postoperative Acute Kidney Injury: Incidence and Outcome - Thorir Einarsson Long, Reykjavik, Iceland

14.15 - 15.00 State of the art lecture Chair: Erik Fjellstedt

Update on ADPKD: From the bench to the bedside - Vicente Torres, Rochester, USA

15.00 - 15.30 Coffee and exhibition

15.30 - 16.30 PD Chair: Aivars Petersons

How to optimize APD? - Carl Öberg, Lund, Sweden

How to increase the number of PD patients - Olof Heimburger, Stockholm, Sweden

Increase in home dialysis, mainly PD - experience from Turku - Kaj Metsärinne, Turku, Finland

16.30 - 17.00 Sponsor lecture - Amgen

Etelcalcetide: A new treatment option in the management of SHPT in haemodialysis patients - Marianne Rix, Copenhagen, Denmark

17.30 Malmö by Boat ”Rundan” - departing from Malmö Live

Friday September 22nd

08.00 - 08.30 Sponsor lecture - Alexion

aHUS in Finland, clinical perspective and recent published guideline suggestions - Kati Kaartinen, Helsinki, Finland

08.30 - 10.00 AutoimmunityChair: Sophie Ohlsson

Grand Rounds with case presentations - Martin Johansson, Malmö, Sweden & Shariar Akaberi, Lund, Sweden,

Knut Aasarød, Trondheim, Norway, Wladimir Spirtz, Copenhagen, Denmark

The role of neutrolphil extracellular traps in ANCA-associated vasculitis - Mårten Segelmark, Linköping, Sweden

10.00 - 10.30 Coffee and exhibition

10.30 - 12.00 Cardiorenal syndrome, early vascular ageing Chair: Inga Soveri

Genetic factors in cardiorenal disease - new clinical implications for prevention and treatment - Olle Melander, Malmö, Sweden

The ageing artery wall - Isabel Goncalves, Malmö, Sweden

The role of novel biomarkers and diet in renal disease - Marju Orho-Melander, Malmö, Sweden

12.00 - 14.00 Lunch and exhibition

13.00 - 14.00 Poster session - several guided groups to join!

14.00 - 14.15 Chair: Karl Dreja

Kidney Disease in Puumala hantavirus infection - Jukka Mustonen, Finland

14.15 - 15.00 State of the art lectureChair: Karl Dreja

Oral anticoagulation in hemodialysis patients: challenges and opportunities - An de Vriese, Brügge, Belgium

15.00 - 15.30 Coffee and exhibition

15.30 - 16.15 State of the art lecture Chair: Jenny Nyström

Aquaporins in the kidney. An update - Søren Nielsen, Århus, Denmark

16.15 - 17.00 Sponsor lecture - Vifor Pharma Chair: Marianne Rix

A paradigm shift in the long-term management of patients with RAASi* and hyperkalemia? - Matthew R. Weir, Baltimore, US & Juan-Jesus Carrero-Roig, Stockholm, Sweden

*Renin-Angiotensin II-Aldosteron-System Inhibitors

19.00-01.00 Banquet dinner at Malmö Town hall - hosted by the city of Malmö

Saturday September 23rd

Chair: Diana Karpman

08.30 - 09.00 Highs and lows of sodium - Detlef Bockenhauer, London, UK

09.00 - 09.30 Cystinosis. What’s new? - Elena Levtchenko, Leuven, Belgium

09.30 - 10.00 Complement mediated renal disease - Sanjeev Sethi, Rochester, USA

10.00 - 10.15 Coffee

10.15 - 11.15 New expensive treatments. Can we afford them? Chair: Runólfur Pálsson & Annette Bruchfeld

Lars Sandman, The council for new therapies, SwedenSteinar Madsen, Medical director Norwegian medicines agencyDouglas Lundin, The dental and phramaceutical benefits agency, SwedenSøren Rittig, Pediatric nephrologist, Professor Aarhus, DenmarkÅsa Magnusson, The commission for innovative and rare pharmaceuticals, Sweden Taina Mäntyranta, General secretary ministry of social affairs and health/Council for choices in health care in Finland

11.15 Concluding remarks & to-go-lunch